Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfizer seeing the deepest ...

The news prompted a sell-off across the industry. In the US, shares in Pfizer and Moderna sank more than 5% in early trading, ...

The inability of COVID vaccines to reach the long-lived plasma cell compartment in the bone marrow may explain their waning ...

GSK collaborates closely with Canadian sites — such as hospitals and other health-care centres — to operationalize its trials ...

Cambridge: Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common ...

Deutsche Bank analyst Emmanuel Papadakis downgraded GSK (GSK) to Hold from Buy with a price target of 1,350 GBp, down from 1,700 GBp.

Shares of several of the world’s largest vaccine makers fell Friday, the day after Donald Trump announced he had selected ...

AstraZeneca and GSK fell as the president-elect named Kennedy as his pick for the role overseeing the US's rules on medicine, ...

The UK stock market experienced declines with significant impacts from AstraZeneca and GSK, contributing to the FTSE 100's ...

Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...

The main UK stock indexes were subdued on Friday, with losses in AstraZeneca and GSK weighing on the blue-chip FTSE 100, ...